Boryung Corporation
Research Boryung Corporation (003850.KS) on Bullrun: market cap KRW 689.11B, dividend yield 1.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker003850.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 689.11B
- Dividend yield1.8%
- Financial periodQ2 2026
- RevenueKRW 279.62B
- Net incomeKRW 24.05B
- Free cash flow-KRW 275.27B
- Gross margin37.4%
Valuation Snapshot
latest market cap is KRW 689.11B; dividend yield is 1.8%.
Peer valuation comparison
Latest dividend yield is 1.82% versus a Healthcare sector median of 2.4% (24.2% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 689.11B | n/a | 1.9% | 160 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 160 KRW, yield 1.8%.
About Boryung Corporation
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
ETFs that hold Boryung Corporation
US-listed ETFs
Boryung Corporation is held by 17 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | <0.01% | 0.06% |
| Dimensional Emerging Core Equity Market ETF (DFAE) | <0.01% | 0.29% |
| Dimensional Emerging Markets Core Equity 2 ETF (DFEM) | <0.01% | 0.39% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Boryung Corporation's market cap?
Boryung Corporation's market capitalization is KRW 689.11B.
Does Boryung Corporation pay a dividend?
Boryung Corporation has a dividend yield of 1.8%.
What does Boryung Corporation do?
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.